Yuuwa Capital

Investor type

VC

Founded

2009

AUM

$40 M

Location

Perth, Western Australia, Australia

Investment Ticket

$0-1 m

Investment Stage

Seed Series A

Region of investment

Australia and others
Investor profile last updated: 26 August, 2026

Profile

Yuuwa Capital is a specialist life sciences commercialization and investment firm based in Western Australia, founded in 2009. It was established as the manager of a $40 million venture capital fund with support from the Australian Federal Government's Innovation Investment Fund and private investors. The firm is co-founded by Liddy McCall and James Williams, both of whom have extensive experience in early-stage startups in the life sciences sector. They bring decades of experience in founding, investing in, and managing biotech companies.

Yuuwa Capital focuses on the life sciences sector, providing both expertise and capital to identify and scale early-stage ventures. Their investments are targeted at early-stage opportunities, helping to start and grow companies in this space. The firm connects specialist early-stage investors with promising ventures but does not have an explicit stage or region focus on the site beyond being centered in Australia.

Notable companies in Yuuwa Capital's portfolio include AdAlta Limited, Agworld Pty Ltd, Fitgenes Australia Limited, iCeutica Inc (acquired), and Dimerix Limited. These investments highlight Yuuwa's focus on biotechnology and life sciences, with a track record of involvement in companies that achieve FDA approval and ASX listing.

Industry

Foodtech Agriculture HealthTech Life Sciences Software Biotechnology Healthcare Services Medical Devices

Contacts

Name
Title
Email
avatar
James Williams Co-Founder and and Investment Director
Co-Founder and and Investment Director
-
avatar
Liddy McCall Co-Founder and Investment Director
Co-Founder and Investment Director
-
Upgrade to see contacts
avatar
eXYhI6xE2SCrkNv3 eXYhI6xE2SCrkNv3
eXYhI6xE2SCrkNv3
avatar
eXYhI6xE2SCrkNv3 eXYhI6xE2SCrkNv3
eXYhI6xE2SCrkNv3
avatar
eXYhI6xE2SCrkNv3 eXYhI6xE2SCrkNv3
eXYhI6xE2SCrkNv3
Investment-team contacts for Yuuwa Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Yuuwa Capital

Yuuwa Capital is a venture capital firm. It backs companies at Seed and Series A, writing tickets of $0-1 m.
Yuuwa Capital is located in Perth, Western Australia, Australia.
Yuuwa Capital was founded in 2009.
Yuuwa Capital invests in companies and startups in Foodtech, Agriculture, HealthTech, Life Sciences, Software, Biotechnology, Healthcare Services, Medical Devices.
Yuuwa Capital invests in companies and startups in Australia and others.
Yuuwa Capital invests in companies and startups at Seed, Series A.
Yuuwa Capital usually invests $0-1 m on average.
Yuuwa Capital has around $40m assets under management.
Yuuwa Capital can be reached through its website yuuwa.com.au and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Yuuwa Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Yuuwa Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 26 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.